Results 131 to 140 of about 48,304 (212)

Patterns of immune recovery after axicabtagene ciloleucel for aggressive B‐cell lymphoma

HemaSphere, Volume 9, Issue 10, October 2025.
Abstract Hematotoxicity after anti‐CD19 chimeric antigen receptor T‐cell therapy has drawn attention for potential long‐term effects, and yet, recovery of lymphocyte subsets and immunoglobulin levels beyond B‐cell aplasia remains poorly understood. We retrospectively analyzed 76 consecutive axicabtagene ciloleucel (axi‐cel) recipients with relapsed ...
André Airosa Pardal, Ana Benzaquén, Pablo Granados, Paula Amat, Rafael Hernani, Aitana Balaguer‐Roselló, Ariadna Pérez, Marta Villalba, Pedro Asensi, Blanca Ferrer, Lourdes Cordón, Irene Pastor‐Galán, Juan Montoro, María José Remigia, Juan Carlos Hernández‐Boluda, Amparo Sempere, Jaime Sanz, María José Terol, Carlos Solano, Pedro Chorão, José Luis Piñana   +20 more
wiley   +1 more source

EHA–EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma

HemaSphere, Volume 9, Issue 10, October 2025.
Abstract Mantle cell lymphoma (MCL) is a relatively rare B‐cell lymphoma subtype, with a higher incidence among males and a median age of 70 years at diagnosis. MCL is characterized by clinically diverse behavior, from indolent disease to extremely aggressive, related to the presence of biological risk factors such as proliferation rate and TP53 ...
Mats Jerkeman, Igor Aurer, Elias Campo, Chan Y. Cheah, Jonathan Clark, Jeanette Doorduijn, Toby A. Eyre, Martin Fehr, Eva Giné, Maria Gomes da Silva, Pavel Klener, Marco Ladetto, Vincent Ribrag, Ofer Shpilberg, Jan Walewski, Martin Dreyling, the EHA Guidelines Committee and the European MCL Network   +16 more
wiley   +1 more source

A Physiologically Based Modeling Approach to Evaluate Intravenous Levetiracetam Dosing in Term and Preterm Neonates

The Journal of Clinical Pharmacology, Volume 65, Issue 10, Page 1246-1261, October 2025.
Abstract Seizures are the most common neurologic emergency in neonates and are associated with significant morbidity and mortality. Current first‐line pharmacotherapy, phenobarbital, is associated with serious adverse effects, including impairment of the developing brain.
Alexis Johnson, Nolan Thomas, Max Blumenthal, Chrysanthy Ikonomidou, Sin Yin Lim   +4 more
wiley   +1 more source

Antifungal Effects of Gold Nanoparticles Conjugated Fluconazole against Fluconazole Resistant Strains of Candida albicans Isolated From Patients with Chronic Vulvovaginitis

Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum, 2016
Background and Objectives: A number of women with volvuvaginal candidiasis suffer from certain chronic and recurrent types of this infection that affect their quality of life. Meanwhile, increased use of antifungal drugs, especially azoles, for treatment
Mehrdad Memarian, Ali Javadi, Roohollah Fateh   +2 more
doaj  

Low-Dose Fluconazole as Primary Prophylaxis for Cryptococcal Infection in AIDS Patients with CD4 Cell Counts of <=100/mm3: Demonstration of Efficacy in a Prospective, Multicenter Trial [PDF]

, 1996
N. Singh, M. J. Barnish, Steven Berman, Bradley S. Bender, Marilyn M. Wagener, M G Rinaldi, Victor L. Yu   +6 more
openalex   +1 more source

Late‐Onset Invasive Aspergillosis With Pituitary Involvement and Dysfunction Following CD19 Chimeric Antigen Receptor T‐Cell Therapy

eJHaem, Volume 6, Issue 5, October 2025.
ABSTRACT Introduction Invasive fungal infection (IFI) after chimeric antigen receptor (CAR) T‐cell therapy is less common than bacterial and viral infections, but can be fatal once it develops. As most cases occur within 30 days after CAR T‐cell infusion, late‐onset IFI—particularly mould infection—appears to be under‐recognised.
Daisuke Ikeda, Tomohiro Nawada, Takumi Kondo, Takayuki Shinohara, Tomohiro Nagano, Saya Kubota, Ryuichiro Hiyama, Masaya Ueno, Hiroki Kobayashi, Keisuke Seike, Hideaki Fujiwara, Noboru Asada, Daisuke Ennishi, Keiko Fujii, Nobuharu Fujii, Masanori Makita, Yoshinobu Maeda   +16 more
wiley   +1 more source

FLUCONAZOLE IN FUNGAL INFECTION

, 1994
Marcus Zervos, Jan F. Silverman, Françoise Meunier   +2 more
openalex   +1 more source

Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B [PDF]

, 1995
Alan M. Sugar, Christopher A. Hitchcock, Peter F. Troke, Michele D. Picard   +3 more
openalex   +1 more source

Carvacrol and Thymol, a Synergistic Antimicrobial Activity Against Bacterial and Candida Species

MicrobiologyOpen, Volume 14, Issue 5, October 2025.
This study assessed antimicrobial efficacy, synergistic interactions, and cytotoxicity against different human cell lines of the natural monoterpenes thymol and carvacrol against bacteria and Candida spp. in both planktonic and biofilm forms. Despite high toxicity at elevated doses, their synergistic/additive interaction supports future therapeutic and
Giulia Radocchia, Andrea Giammarino, Sabrina Barberini, Laura Verdolini, Marta De Angelis, Giovanna Simonetti, Fabrizio Pantanella, Serena Schippa, Letizia Angiolella   +8 more
wiley   +1 more source

Minimum Inhibitory Concentrations of Anidulafungin as a Potential Predictor of Biocide Susceptibility of Clade 1 Candidozyma (Candida) auris Isolates

MicrobiologyOpen, Volume 14, Issue 5, October 2025.
Our study shows that a decision tree trained on antifungal MIC profiles, especially anidulafungin, can predict how susceptible Candida auris is to triclosan, chlorine, and chlorhexidine. This shows a possible way to cut down on routine biocide testing in infection control surveillance. ABSTRACT Candidozyma (Candida) auris is a multidrug‐resistant yeast
Sidre Erganis, Ayse Seyer, Mubarak Taiwo Mustapha, Meliz Yuvali, Furkan Martli, Sena Algin, Sema Turan Uzuntas, Beyza Yavuz, Alper Dogan, Esra Kılıc, Fusun Kirca, Abdullahi Garba Usman, Elif Ayca Sahin, Cagrı Ergin, Bedia Dinc, Dilber Uzun Ozsahin, Ayse Kalkanci   +16 more
wiley   +1 more source